CTKB
Cytek Biosciences Inc
NASDAQ: CTKB · HEALTHCARE · MEDICAL DEVICES
$4.56
+2.70% today
Updated 2026-04-30
Market cap
$565.62M
P/E ratio
—
P/S ratio
2.81x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$2 – $6
Volume
0.7M
Cytek Biosciences Inc (CTKB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
+8.1%
Most recent quarter
EPS YoY growth
-337.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+9.3%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+16.1%
2025-11-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $-0.29 | -1495.6% | $4.37 | $4.48 | +2.5% |
| 2025-11-05 | $-0.04 | -33.3% | $3.91 | $4.54 | +16.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.02 | $-0.29 | -1495.6% | $62.14M | +8.1% |
| 2025-09-30 | $-0.03 | $-0.04 | -33.3% | $52.29M | +1.5% |
| 2025-06-30 | $-0.04 | $-0.04 | +0.0% | $45.60M | -2.2% |
| 2025-03-31 | $-0.04 | $-0.03 | +32.0% | $41.46M | -7.6% |
| 2024-12-31 | $0.11 | $0.12 | +9.8% | $57.48M | -1.3% |
| 2024-09-30 | $0.01 | $0.01 | +0.0% | $51.50M | +7.3% |
| 2024-06-30 | $-0.03 | $-0.08 | -166.7% | $46.62M | -6.2% |
| 2024-03-31 | $-0.04 | $-0.05 | -25.0% | $44.86M | — |
| 2023-12-31 | $0.01 | $0.04 | +300.0% | $58.23M | — |
| 2023-09-30 | $0.03 | $-0.05 | -266.7% | $48.00M | — |
| 2023-06-30 | $0.03 | $-0.03 | -200.0% | $49.69M | — |
Frequently asked questions
Has Cytek Biosciences Inc beaten earnings estimates?
Cytek Biosciences Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports.
How does CTKB stock react to earnings?
CTKB stock has moved an average of +9.3% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Cytek Biosciences Inc's revenue growth rate?
Cytek Biosciences Inc reported year-over-year revenue growth of +8.1% in its most recent quarter, with EPS growing -337.7% year-over-year.